← Back to all earnings calls

Sutro Biopharma, Inc. Q3 FY2024 Earnings Call

Sutro Biopharma, Inc. (STRO)

Earnings Call FY2024 Q3 Call date: 2024-11-13 Concluded

Share

Quarter scorecard

Revenue

$8.52M

-49.7% YoY

Diluted EPS

$-5.90

Net income

-$48.79M

Documents & deck